(Q44544392)

English

Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium (English)

1 reference

Europe PubMed Central

4 December 2017

serous carcinoma

1 reference

based on heuristic

inferred from title

ovarian serous carcinoma

1 reference

based on heuristic

inferred from title

6

object named as

Anais Malpica

1 reference

Europe PubMed Central

4 December 2017

3

object named as

Karen H Lu

1 reference

Europe PubMed Central

4 December 2017

David Gershenson

9

object named as

David M Gershenson

1 reference

Europe PubMed Central

4 December 2017

author name string

Rosemarie E Schmandt

1

1 reference

Europe PubMed Central

4 December 2017

Russell Broaddus

2

1 reference

Europe PubMed Central

4 December 2017

Hyun Shvartsman

4

1 reference

Europe PubMed Central

4 December 2017

Angela Thornton

5

1 reference

Europe PubMed Central

4 December 2017

Charlotte Sun

7

1 reference

Europe PubMed Central

4 December 2017

Diane C Bodurka

8

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

98

1 reference

Europe PubMed Central

4 December 2017

758-764

1 reference

Europe PubMed Central

4 December 2017

4

1 reference

Europe PubMed Central

4 December 2017

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical management of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Part II: chemotherapy for epithelial ovarian cancer-treatment of recurrent disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Current clinical practices for ovarian cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Future directions in the treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

The protein tyrosine kinase family of the human genome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogenic kinase signalling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Rational therapeutic intervention in cancer: kinases as drug targets

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Receptor tyrosine kinases as targets for anticancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Smart drugs: tyrosine kinase inhibitors in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of inhibitors for protein tyrosine kinases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein kinases as targets for anticancer agents: from inhibitors to useful drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

STI571 (Gleevec) as a paradigm for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of the tyrosine kinase inhibitor STI571 in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent advancements in the treatment of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

The GIST of targeted cancer therapy: a tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

An overview of translocation-related oncogenesis in the chronic myeloid leukaemias

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional tyrosine kinase inhibitor profiling: a generally applicable method points to a novel role of platelet-derived growth factor receptor-beta in tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Abl: mechanisms of regulation and activation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Signaling pathways activated by oncogenic forms of Abl tyrosine kinase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Abl expression in human fetal and adult tissues, tumours, and tumour microvessels

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of action and in vivo role of platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Developmental roles of platelet-derived growth factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet-derived growth factor receptors: a therapeutic target in solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Human ovarian tumors of epithelial origin express PDGF in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Germ cell specific expression of c-kit in the human fetal gonad

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Roles of KIT and KIT LIGAND in ovarian function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression and action of kit ligand/stem cell factor in normal human and bovine ovarian surface epithelium and ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Autocrine interactions of keratinocyte growth factor, hepatocyte growth factor, and kit-ligand in the regulation of normal ovarian surface epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of expression of c-KIT in ovarian cancers is associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11561

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.11561

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44544392&oldid=2034405023"